MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 31 filers reported holding MYOVANT SCIENCES LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $128,000 | -77.0% | 16,953 | -52.7% | 0.01% | -33.3% |
| Q4 2019 | $556,000 | +243.2% | 35,819 | +56.3% | 0.02% | +150.0% |
| Q2 2019 | $162,000 | -44.3% | 22,915 | +87.9% | 0.01% | -50.0% |
| Q1 2019 | $291,000 | +44.8% | 12,195 | +60.9% | 0.01% | +50.0% |
| Q3 2018 | $201,000 | – | 7,581 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $71,647,000 | 83.05% |
| VR Adviser, LLC | 845,000 | $17,424,000 | 4.17% |
| Opaleye Management Inc. | 682,500 | $14,073,000 | 2.84% |
| Eversept Partners, LP | 760,551 | $15,682,562 | 2.15% |
| Cormorant Asset Management, LP | 2,500,000 | $51,550,000 | 1.97% |
| Ghost Tree Capital, LLC | 300,000 | $6,186,000 | 1.63% |
| Bellevue Group AG | 4,647,000 | $95,821,000 | 1.36% |
| Aristides Capital LLC | 67,000 | $1,382,000 | 1.04% |
| Amia Capital LLP | 27,070 | $558,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 150,000 | $3,093,000 | 0.33% |